GFA
8783
Chiome Bioscience
4583
Pluszero
5132
Pixel
2743
GreenBee
3913
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -16.37%2.37B | -3.36%604.46M | 1.20%574.74M | -35.92%493.2M | -19.91%697.35M | -10.55%2.83B | -29.92%625.5M | -22.00%567.9M | -8.03%769.66M | 22.55%870.66M |
Cost of revenue | -22.92%1.4B | -11.72%334.05M | -6.89%344.07M | -38.44%302.77M | -27.26%423.24M | -10.94%1.82B | -33.97%378.4M | -16.27%369.51M | -16.97%491.79M | 32.66%581.85M |
Gross profit | -4.60%965.61M | 9.43%270.41M | 16.27%230.67M | -31.47%190.43M | -5.09%274.11M | -9.84%1.01B | -22.65%247.1M | -30.81%198.38M | 13.64%277.87M | 6.23%288.8M |
Operating expense | 11.33%1.26B | 14.07%314.33M | 9.22%312.81M | 13.50%310.24M | 8.78%318.61M | 2.64%1.13B | 3.89%275.55M | 5.28%286.39M | 0.46%273.34M | 1.07%292.89M |
Staff costs | 16.25%691.37M | ---- | ---- | ---- | ---- | -4.27%594.71M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | 5.91%359.58M | ---- | ---- | ---- | ---- | 21.08%339.5M | ---- | ---- | ---- | ---- |
-Selling and marketing expense | 14.48%18.39M | ---- | ---- | ---- | ---- | 27.56%16.06M | ---- | ---- | ---- | ---- |
-General and administrative expense | 5.49%341.19M | ---- | ---- | ---- | ---- | 20.77%323.44M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 6.92%58.92M | ---- | ---- | ---- | ---- | -16.41%55.11M | ---- | ---- | ---- | ---- |
-Depreciation | 6.92%58.92M | ---- | ---- | ---- | ---- | -16.41%55.11M | ---- | ---- | ---- | ---- |
Rent and land expenses | 10.35%53.94M | ---- | ---- | ---- | ---- | 7.36%48.88M | ---- | ---- | ---- | ---- |
Other operating expenses | 2.44%92.18M | ---- | ---- | ---- | ---- | 4.56%89.98M | ---- | ---- | ---- | ---- |
Operating profit | -150.28%-290.37M | -54.35%-43.92M | 6.67%-82.14M | -2,744.77%-119.81M | -989.35%-44.5M | -595.10%-116.02M | -152.47%-28.46M | -698.75%-88.01M | 116.43%4.53M | 77.21%-4.09M |
Net non-operating interest income (expenses) | 20.56%-1.05M | -12.12%-296K | -0.86%-353K | 86.40%-48K | 0.28%-350K | -109.87%-1.32M | 23.26%-264K | 0.00%-350K | -0.57%-353K | -184.17%-351K |
Non-operating interest income | 302.22%362K | -29.07%61K | --0 | ---- | ---- | -88.43%90K | 1,333.33%86K | --0 | ---- | ---- |
Non-operating interest expense | 0.07%1.41M | 2.00%357K | 0.86%353K | -2.24%349K | -0.28%350K | 0.14%1.41M | 0.00%350K | 0.00%350K | 0.56%357K | 0.00%351K |
Net investment income | 89.49%-1.07M | -231.77%-983K | 68.16%-2.36M | 240.09%1.48M | 132.29%794K | -181.26%-10.18M | 137.02%746K | -603.51%-7.41M | -79.73%-1.06M | -6,745.95%-2.46M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -3,816.38%-124.09M | -1,864.68%-123.1M | -131.91%-292K | 50.42%-179K | 87.71%-515K | -93.85%3.34M | 17.68%6.98M | -52.07%915K | -100.77%-361K | -1,100.86%-4.19M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | 0 | 0 | 0 | 0 | 142K | 142K | 0 | 0 | 0 |
Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---142K | ---- | ---- | ---- | ---- |
Other non-operating income (expenses) | 176.94%3.24M | 242.78%1.38M | -3.67M | -96.02%8K | 185.93%5.53M | -8.87%1.17M | -448.91%-963K | 0 | -20.24%201K | 1,758.65%1.93M |
Income before tax | -236.40%-413.35M | -664.69%-166.94M | 6.37%-88.81M | -4,102.33%-118.55M | -326.57%-39.04M | -264.31%-122.87M | -137.60%-21.83M | -698.13%-94.85M | -84.05%2.96M | 48.33%-9.15M |
Income tax | 1,176.43%34.72M | 532.25%26.05M | 16.35%7.72M | -16.19%-4.1M | -10.51%5.05M | 253.33%2.72M | -139.26%-6.03M | 102.47%6.64M | -1,334.97%-3.53M | 300.28%5.64M |
Net income | -256.75%-448.07M | -1,121.08%-192.99M | 4.88%-96.53M | -1,862.30%-114.44M | -197.99%-44.1M | -264.05%-125.6M | -126.09%-15.81M | -906.72%-101.49M | -64.49%6.49M | 0.66%-14.8M |
Net income continuous operations | -256.76%-448.07M | -1,121.16%-192.99M | 4.88%-96.53M | -1,862.32%-114.45M | -198.00%-44.1M | -264.05%-125.59M | -126.09%-15.8M | -906.67%-101.49M | -64.49%6.49M | 0.66%-14.8M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -256.75%-448.07M | -1,121.08%-192.99M | 4.88%-96.53M | -1,862.30%-114.44M | -197.99%-44.1M | -264.05%-125.6M | -126.09%-15.81M | -906.72%-101.49M | -64.49%6.49M | 0.66%-14.8M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -256.75%-448.07M | -1,121.08%-192.99M | 4.88%-96.53M | -1,862.30%-114.44M | -197.99%-44.1M | -264.05%-125.6M | -126.09%-15.81M | -906.72%-101.49M | -64.49%6.49M | 0.66%-14.8M |
Gross dividend payment | ||||||||||
Basic earnings per share | -256.82%-117.43 | -1,121.74%-50.58 | 4.89%-25.3 | -1,864.71%-30 | -198.45%-11.55 | -264.06%-32.91 | -126.07%-4.14 | -906.06%-26.6 | -64.44%1.7 | 0.77%-3.87 |
Diluted earnings per share | -256.82%-117.43 | -1,121.09%-50.58 | 4.89%-25.3 | -1,864.71%-30 | -198.45%-11.55 | -264.06%-32.91 | -126.09%-4.1422 | -906.80%-26.6 | -64.44%1.7 | 0.77%-3.87 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |